Extensive studies have not found increased cancer risk in people using GLP-1 medications for several years
The investigated GLP-1 receptor agonists included liraglutide, albiglutide, dulaglutide, exenatide, semaglutide, and lixisenatide
Begin Your Journey by clicking the link : This article should be used as an educational resource to help you explore lifestyle habits, selfmanagement techniques, and wellness
So far so good, I have had zero side effects from it as well
In contrast, 43% said the same about those who use dieting as a weight-loss method
AID: automated insulin delivery) Continuous Glucose Monitoring (CGM) is reaffirmed as the standard of care for everyone with type 1 diabetes, with fingerstick testing as backup